Internal Medicine Alert – January 15, 2009
January 15, 2009
View Issues
-
(Doctor) Shop Till You Drop
Most deaths due to overdose in West Virginia involved men who took opioids that were not prescribed for them. -
Early Stage Prostate Cancer Unlikely to Affect Survival
Older men with early stage prostate cancer had survival similar to those without cancer; for two-thirds of these men, cardiovascular diseases and other cancers were more likely to cause death than prostate cancer. -
Diagnose Frailty to Help Vulnerable Elderly
Strong evidence was found that slow gait speed, low physical activity, and weight loss are key indicators of frailty, which is associated with chronic disability, long-term nursing home stays, injurious falls, and death. -
Pharmacology Update: Fesoterodine Fumarate Extended Release Tablets (Toviaz™)
The FDA has approved a new muscarinic receptor antagonist for the treatment of overactive bladder. -
Clinical Briefs By Louis Kuritzky, MD
The syllogistic process that led us all to accept the utility of ASA in prevention of CVD in diabetics seemed innocent enough: a) ASA reduces CV events in persons with CVD, and b) diabetes is considered a CV risk equivalent; therefore, c) ASA must reduce CV events in persons with diabetes. -
ECG Review: How Wide Is the QRS?
The lead II rhythm strip shown above was obtained from an elderly patient with shortness of breath. How wide is the QRS complex? -
Pharmacology Watch
The JUPITER trial causes a stir; ACP practice guideline for antidepressant use; testosterone for low libido; continued shortage of Hib vaccine; FDA Actions.